SAN DIEGO, Nov. 24, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global leader of in vitro diagnostics, announced today that members of its management team will participate in two upcoming investor conferences:

• Evercore ISI 8th Annual Healthcare Conference, Tuesday, December 2, 2025
  Members of QuidelOrtho's management team are scheduled to participate in a fireside chat at 10:00 a.m. ET / 7:00 a.m. PT.
  
  
• Citi Global Healthcare Conference, Wednesday, December 3, 2025
  Members of QuidelOrtho's management team are scheduled to participate in a fireside chat at 1:00 p.m. ET / 10:00 a.m. PT.

Interested parties can access the live webcast and replay in the "Events & Presentations" section of the "Investor Relations" page of QuidelOrtho's website at https://ir.quidelortho.com/.

QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.

About QuidelOrtho Corporation

With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, delivering fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.

Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.